Seoul
South Korea
3
2022-09-29
3
2025-03-11
These are the the leading inventors for applications assigned to GENCELLMED INC.:
GENCELLMED INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Recombinant herpes simplex virus having modified glycoprotein gH for retargeting and use thereof
#2 | 2022-09-29 ✅ Patent 12,629,399 granted on 2026-05-19RECOMBINANT HERPES SIMPLEX VIRUS FOR MULTIPLE TARGETING AND USE THEREOF
#3 | 2021-02-25 ✅ Patent 11,421,017 granted on 2022-08-23Recombinant herpes simplex virus having expression cassette expressing fused protein of cancer cell-targeting domain and extracellular domain of HVEM and use thereof
Also check out Gencellmed Inc.'s (Seoul, South Korea) applicant profile with 3 patent applications submitted.
384857 ⎘